Literature DB >> 10893335

Renal resistance to vasopressin in poorly controlled type 1 diabetes mellitus.

K McKenna1, A D Morris, M Ryan, R W Newton, B M Frier, P H Baylis, T Saito, S Ishikawa, C J Thompson.   

Abstract

To investigate the hypothesis that diabetes induces nephrogenic diabetes insipidus, we studied the urine-concentrating ability in response to vasopressin (AVP) in 12 patients with insulin-dependent diabetes mellitus (IDDM) and 12 nondiabetic controls. Subjects were euglycemic-clamped, and after oral water loading, AVP was infused intravenously for 150 min. AVP induced a greater (P<0.001) rise in urine osmolality in controls (67.6+/-10.7 to 720+/-31.1 mosmol/kg, P<0.001) than in IDDM patients (64.3+/-21.6 to 516.7+/-89.3 mosmol/kg, P<0.001). Urinary aquaporin-2 concentrations after AVP infusion were higher in controls (611.8+/-105.6 fmol/mg creatinine) than in IDDM (462.0+/-94.9 fmol/mg creatinine, P = 0. 003). Maximum urine osmolality in IDDM was inversely related to chronic blood glucose control, as indicated by Hb A(Ic) (r = -0.87, P = 0.002). To test the hypothesis that improved glycemic control could reverse resistance to AVP, 10 IDDM subjects with poor glycemic control (Hb A(Ic) >9%) were studied before (B) and after (A) intensified glycemic control. Maximum urine osmolality in response to AVP increased with improved glycemic control (B, 443.8+/-49.0; A, 640.0+/-137.2 mosmol/kg, P<0.001), and urinary aquaporin-2 concentrations after AVP increased from 112.7 +/-69 to 375+/-280 fmol/mg creatinine (P = 0.006), with improved glycemic control. Poorly controlled IDDM is associated with reversible renal resistance to AVP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893335     DOI: 10.1152/ajpendo.2000.279.1.E155

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  11 in total

1.  5-Carbamoylmethyluridine: a new minor nucleoside of transfer ribonucleic acid.

Authors:  D B Dunn; M M Trigg
Journal:  Biochem Soc Trans       Date:  1975       Impact factor: 5.407

2.  A complicated hyperglycaemic emergency.

Authors:  Madhurima Vidyarthi; Tahseen A Chowdhury
Journal:  Clin Med (Lond)       Date:  2010-06       Impact factor: 2.659

3.  Renal distal tubule proliferation and increased aquaporin 2 level but decreased urine osmolality in db/db mouse: treatment with chromium picolinate.

Authors:  Mahmood S Mozaffari; Rafik Abdelsayed; Jun Yao Liu; Ibrahim Zakhary; Babak Baban
Journal:  Exp Mol Pathol       Date:  2011-09-29       Impact factor: 3.362

4.  Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat.

Authors:  Tadeusz Pawelczyk; Marzena Grden; Robert Rzepko; Monika Sakowicz; Andrzej Szutowicz
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

5.  Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patients.

Authors:  Takahiro Masuda; Ken Ohara; Izumi Nagayama; Ryo Matsuoka; Takuya Murakami; Saki Nakagawa; Kentanro Oka; Maki Asakura; Yusuke Igarashi; Yukimura Fukaya; Yasuharu Miyazawa; Akito Maeshima; Tetsu Akimoto; Osamu Saito; Daisuke Nagata
Journal:  Int Urol Nephrol       Date:  2019-06-03       Impact factor: 2.370

Review 6.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

7.  Identification of hub genes related to the progression of type 1 diabetes by computational analysis.

Authors:  G Prashanth; Basavaraj Vastrad; Anandkumar Tengli; Chanabasayya Vastrad; Iranna Kotturshetti
Journal:  BMC Endocr Disord       Date:  2021-04-07       Impact factor: 2.763

8.  PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes.

Authors:  Ramzi Hassouneh; Rania Nasrallah; Joe Zimpelmann; Alex Gutsol; David Eckert; Jamie Ghossein; Kevin D Burns; Richard L Hébert
Journal:  Diabetologia       Date:  2016-03-19       Impact factor: 10.122

9.  Enhanced expressions of arginine vasopressin (Avp) in the hypothalamic paraventricular and supraoptic nuclei of type 2 diabetic rats.

Authors:  Sun Shin Yi; In Koo Hwang; Yo Na Kim; Il Yong Kim; Son-Il Pak; In Se Lee; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

10.  Aqp5 is a new transcriptional target of Dot1a and a regulator of Aqp2.

Authors:  Hongyu Wu; Lihe Chen; Xi Zhang; Qiaoling Zhou; Ju-Mei Li; Stefan Berger; Zea Borok; Beiyun Zhou; Zhou Xiao; Hongling Yin; Mingyao Liu; Ying Wang; Jianping Jin; Michael R Blackburn; Yang Xia; Wenzheng Zhang
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.